Key Takeaways

A lower dose of an immunotherapy drug might help patients better fight melanoma

A 'flipped' dose of an immunotherapy cocktail of nivolumab/ipilimumab provided better results with fewer side effects

The flipped dose swaps the standard dosage recommended for nivolumab and ipilimumab

FRIDAY, Dec. 12, 2025 (HealthDay News) — Less might be more when it comes to immunotherapy treatment of melanoma , a new study says.

Lower doses of a drug used to treat melanoma can provide better results while reducing side effects, researchers reported Dec. 8 in the Journal of the National Cancer Institute .

“The results are highly interesting in oncology, as we show that a lower dose of an immunotherapy drug, in addition to causing significantly fewer side effects, actually gives bett

See Full Page